President, Global Scientific Communications & Message Impact
If you ask Jill, a 21-year veteran of GCI Health, about the emerging trends facing the healthcare industry you will see what it means to truly know your subject matter and how to communicate it with contagious energy and simplicity. A member of the New York State Bar, Jill brings sharp analytical skills to challenges in the oncology, biotechnology, psychiatric, cardiovascular, and CNS arenas and also excels at communicating technical, high-science and esoteric information in ways that resonate with a variety of audiences. She has led pre and post-approval strategies for such clients as Biogen Idec, Pfizer, Boehringer Ingelheim, Takeda, Lundbeck and Genentech, has led campaigns to protect blockbuster brands and has provided crisis management counsel to companies in the national spotlight. Jill regularly media trains corporate executives and external spokespeople, including physicians, researchers, celebrities and patients and often speaks on issues related to healthcare communication and trends.